Blue Granite Capital’s Amgen AMGN Stock Holding History

Blue Granite Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,174	Closed	-$592K	–	108
2017 Q3	$592K	Buy	+3,174	New	+$562K	0.41%	71

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Blue Granite Capital's AMGN Position: Q4 2017 in Review

Blue Granite Capital sold out of Amgen (AMGN) in Q4 2017, closing a stake of 3,174 shares — an estimated $592K sold.

Blue Granite Capital first reported a position in AMGN in Q3 2017 and held it in 1 quarter. The position peaked at $592K in Q3 2017. 1,734 funds tracked by Wall St. Rank hold AMGN as of Q4 2017.

Blue Granite Capital reported no remaining Amgen position as of Q4 2017 after selling out during the quarter.
Blue Granite Capital sold 3,174 Amgen shares in Q4 2017, an estimated $592K.
Blue Granite Capital first reported a position in Amgen in Q3 2017 and held it in 1 quarter.
Blue Granite Capital's Amgen position peaked at $592K in Q3 2017.
1,734 funds tracked by Wall St. Rank held Amgen as of Q4 2017.

Based on Blue Granite Capital's 13F filing for Q4 2017, filed 14 Feb 2018.